Premature Ejaculation

The EAU 2026 premature ejaculation pathway — a history-based, multi-dimensional diagnosis (self-estimated IELT, perceived control, distress) with classification into lifelong, acquired, variable and subjective PE, treating any underlying ED, prostatitis or other cause first, then approved on-demand pharmacotherapy (dapoxetine, lidocaine/prilocaine spray), off-label escalation to daily SSRIs, clomipramine or on-demand tramadol, and the refractory options. Switch between the visual Pathway map and the phase-by-phase Explorer.